Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

7.3%

9 terminated/withdrawn out of 123 trials

Success Rate

83.9%

-2.6% vs industry average

Late-Stage Pipeline

16%

20 trials in Phase 3/4

Results Transparency

2%

1 of 47 completed trials have results

Key Signals

24 recruiting1 with results7 terminated

Enrollment Performance

Analytics

N/A
45(44.6%)
Phase 1
19(18.8%)
Phase 3
19(18.8%)
Phase 2
17(16.8%)
Phase 4
1(1.0%)
101Total
N/A(45)
Phase 1(19)
Phase 3(19)
Phase 2(17)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (123)

Showing 20 of 123 trials
NCT07412197Phase 1Not Yet Recruiting

Preventive Dendritic Cell Vaccination for Lynch Syndrome

Role: collaborator

NCT01558921Phase 3Active Not Recruiting

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

Role: collaborator

NCT07530887Phase 3Recruiting

NO Re-excision MelanomA - NORMA 2

Role: collaborator

NCT02758951Phase 2Active Not Recruiting

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Role: collaborator

NCT04347616Phase 1Terminated

Natural Killer-cell Therapy for Acute Myeloid Leukemia

Role: collaborator

NCT06931769Recruiting

TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer

Role: collaborator

NCT06452485Recruiting

Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer

Role: collaborator

NCT05645237Active Not Recruiting

HRQOL in Prostate Cancer Patients Treated With Radiotherapy

Role: collaborator

NCT05371158Not ApplicableTerminated

Effectiveness of Online ACT for Pain Interference in Cancer Survivors With Chronic Painful CIPN

Role: collaborator

NCT06989814Not ApplicableRecruiting

Smart Measurement of Circulating Tumor DNA

Role: collaborator

NCT06493734Not ApplicableRecruiting

Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma

Role: collaborator

NCT02284308Active Not Recruiting

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

Role: collaborator

NCT07046884Not ApplicableRecruiting

Improving Personalized Treatment in Oncology: Effects of Integrated Oncological Decision-making

Role: collaborator

NCT07020260Phase 1Not Yet Recruiting

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

Role: collaborator

NCT02331914Completed

GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

Role: collaborator

NCT02271828Not ApplicableActive Not Recruiting

Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy

Role: collaborator

NCT01315015Not ApplicableCompleted

Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial

Role: collaborator

NCT04125277Not ApplicableActive Not Recruiting

The SONImage Study

Role: collaborator

NCT04302454Phase 3Active Not Recruiting

Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy

Role: collaborator

NCT03191110Active Not Recruiting

The COLON Study: Colorectal Cancer Cohort

Role: collaborator